Search Results - "Latacz, E."

Pathological features of vessel co-option versus sprouting angiogenesis by Latacz, Emily, Caspani, Elisabetta, Barnhill, Raymond, Lugassy, Claire, Verhoef, Cornelis, Grünhagen, Dirk, Van Laere, Steven, Fernández Moro, Carlos, Gerling, Marco, Dirix, Marie, Dirix, Luc Y., Vermeulen, Peter B.

“…Cancer cells can use existing blood vessels to acquire a vasculature. This process is termed ‘vessel co-option’. Vessel co-option is an alternative to the…”
Get full text

EP-1597: Dose-escalation for early salvage radiotherapy in prostate cancer improves bDFS by Latacz, E., Dirix, P., De Laere, B., Van Dam, P., Meijnders, P., Huget, P., Verellen, D.

Get full text

Abstract PD9-08: Breast cancer liver metastases vascularize by vessel co-option, not angiogenesis, and have a desert immune phenotype: A histopathological and gene expression study by Vermeulen, PB, van Dam, P-J, Daelemans, S, Latacz, E, Joye, I, Kockx, M, Dirix, P, Verhoef, K, Grunhagen, D, Huget, P, Van Laere, S, Dirix, LY

“…Abstract Phase 3 trials of bevacizumab combined with chemotherapy in metastatic breast cancer have consistently failed to demonstrate a survival benefit for…”
Get full text